Position in AURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,944,000
+$289,274 QoQ
Shares Held
4,640,000
-4.9% QoQ
Ownership
4.47%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#6
of 146 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 125 Biotechnology names. AURA ranks #34 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in AURA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,944,000 | 4,640,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $32,654,726 | 4,881,125 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,602,131 | 4,881,125 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,165,352 | 4,881,125 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,555,842 | 4,881,125 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,603,392 | 4,881,125 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,122,847 | 4,881,125 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,490,823 | 4,881,125 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,930,600 | 4,885,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,050,250 | 4,465,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $37,433,500 | 4,225,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,788,750 | 2,875,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,468,500 | 2,710,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $25,148,800 | 2,710,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,393,759 | 2,132,739 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,295,762 | 1,451,201 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,089,691 | 1,276,619 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,534,418 | 1,297,019 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,318,050 | 1,255,480 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||